Hematopoietic Growth Factors in Oncology

Herausgegeben:Lyman, Gary; Dale, David C.

• Gebundenes Buch

Produktbeschreibung

This volume reviews and integrates the major advances in our understanding of the underlying molecular biology and pharmacology of hematopoietic growth factors in oncology. The results of well designed and executed randomized controlled trials are included.

Produktdetails

• Cancer Treatment and Research 157
• Verlag: Springer / Springer US / Springer, Berlin
• Artikelnr. des Verlages: 12510214, 978-1-4419-7072-5
• 2011
• Seitenzahl: 452
• Erscheinungstermin: 8. November 2010
• Englisch
• Abmessung: 241mm x 160mm x 28mm
• Gewicht: 792g
• ISBN-13: 9781441970725
• ISBN-10: 144197072X
• Artikelnr.: 30201634

Inhaltsangabe

Introduction to the Hematopoietic Growth Factors.
Early
Acting Hematopoietic Growth Factors: Biology and Clinical Experience.
Granulocyte Colony
Stimulating Factors.
Erythropoietic
Stimulating Agents.
Thrombopoietin Factors.
Cyclic and Chronic Neutropenia.
The Myeloid Growth Factors.
Meta
analyses of Randomized Controlled Trials of Granulocyte Colony
Stimulating Factor Prophylaxis in Adult Cancer Patients Receiving Chemotherapy.
Summary and Comparison of Myeloid Growth Factor Guidelines In Patients Receiving Cancer Chemotherapy.
Granulocyte Colony
Stimulating Factors and Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Do Erythropoietic Stimulating Agents Relieve Fatigue? A Review of Review.
Randomized Controlled Trials of the Erythroid
Stimulating Agents in Cancer Patients.
Ten Years of Meta
Analyses on Erythropoiesis
Stimulating Agents in Cancer Patients.
Clinical Practice Guidelines for the Use of Erythroid
Stimulating Agents: ASCO, EORTC, NCCN.
Thrombocytopenia and Platelet Transfusions in Patients With Cancer.
Romiplostim.
Clinical Trials of the Thrombopoietic Mimetic Agents: ELTROMBOPAG.
The Hematopoietic Growth Factors in Acute Leukemia: US Perspective.
The Hematopoietic Growth Factors in Acute Leukemia: A European Perspective.
The Hematopoietic Growth Factors in the Myelodysplastic Syndromes.
The Hematopoietic Growth Factors in Older Cancer Patients.
The Economics of the Hematopoietic Growth Factors